노바백스(NVAX)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $9.95 (-0.50%), 시가총액 $1.49B, 52주 최저~최고 $6.22 ~ $11.19.
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
노바백스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
노바백스의 현재 주가는 $9.95 (-0.50%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
노바백스의 시가총액은 약 $1.49B입니다.
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationall